Infliximab in ulcerative colitis: Real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study)

1. Fernández-Salazar, L.
2. Muñoz, F.
3. Barrio, J.
4. Muñoz, C.
5. Pajares, R.
6. Rivero, M.
7. Prieto, V.
8. Legido, J.
9. Bouhmidi, A.
10. Herranz, M.
11. Fernández, N.
12. Sánchez-Ocaña, R.
13. Joao, D.
14. Santos, F.